Related references
Note: Only part of the references are listed.Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
Ruilin Lei et al.
ONCOTARGETS AND THERAPY (2017)
The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186
Yuan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Targeting noncoding RNAs in disease
Brian D. Adams et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A
Wanjun Li et al.
ONCOLOGY LETTERS (2017)
Long Noncoding RNA H19/miR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway
Jin Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382
Liang Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer
Chunfeng Pan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1
Mingxi Zeng et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)
MiR-129-5p Inhibits Proliferation and Invasion of Chondrosarcoma Cells by Regulating SOX4/Wnt/β-Catenin Signaling Pathway
Peng Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1
Kenzui Taniue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Functions and mechanisms of long noncoding RNAs in lung cancer
Zhenzi Peng et al.
ONCOTARGETS AND THERAPY (2016)
miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin
Yongzhou Zhang et al.
ONCOLOGY LETTERS (2016)
Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression
Hui-yuan Zhai et al.
MEDICAL SCIENCE MONITOR (2016)
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205
Hiroshi Hirata et al.
CANCER RESEARCH (2015)
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
Haibing Xiao et al.
ONCOTARGET (2015)
MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET
Lijun Duan et al.
FEBS LETTERS (2014)
Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice
Rui Kang et al.
GASTROENTEROLOGY (2014)
Hepatocyte-Specific High-Mobility Group Box 1 Deletion Worsens the Injury in Liver Ischemia/Reperfusion: A Role for Intracellular High-Mobility Group Box 1 in Cellular Protection
Hai Huang et al.
HEPATOLOGY (2014)
HMGB1 in health and disease
Rui Kang et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC
MingHua Li et al.
PLOS ONE (2013)
Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection
Hideyuki Yanai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
Oliver J. Stoetzer et al.
TUMOR BIOLOGY (2013)
Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma
Wei Wang et al.
ONCOLOGY LETTERS (2013)
HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells
Chunhong Wang et al.
CANCER BIOLOGY & THERAPY (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
No-Nonsense Functions for Long Noncoding RNAs
Takashi Nagano et al.
CELL (2011)
Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies
Yikyung Park et al.
CANCER CAUSES & CONTROL (2010)
Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer
Jian-fang Liang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer
Yukiko Moriwaka et al.
PATHOBIOLOGY (2010)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
Ewan Birney et al.
NATURE (2007)
Masquerader: High mobility group box-1 and cancer
Jessica E. Ellerman et al.
CLINICAL CANCER RESEARCH (2007)
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas
R. Lin et al.
ONCOGENE (2007)
Phenotypic characterization of endometrial stromal sarcoma of the uterus
K Yamada et al.
CANCER SCIENCE (2006)
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
K Völp et al.
GUT (2006)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
microRNAs: Tiny regulators with great potential
V Ambros
CELL (2001)
Share Paper
